cytosine has been researched along with Herpes Zoster in 9 studies
Herpes Zoster: An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Herpes simplex virus (HSV) reactivations are usually prevented by acyclovir (ACV) prophylaxis, whereas cidofovir (CDV) has been used off indication to manage AdV infections." | 7.83 | Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation. ( Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S, 2016) |
| " We report successful BCV use in management of disseminated acyclovir- and cidofovir-resistant varicella zoster virus in an immunocompromised hematopoietic stem cell transplant patient with chronic graft-versus-host disease who was intolerant to foscarnet." | 3.83 | Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host. ( Hartline, CB; Larson, RA; Mommeja-Marin, H; Mullane, KM; Nuss, C; Prichard, MN; Ridgeway, J; Theusch, J, 2016) |
| " Herpes simplex virus (HSV) reactivations are usually prevented by acyclovir (ACV) prophylaxis, whereas cidofovir (CDV) has been used off indication to manage AdV infections." | 3.83 | Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation. ( Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S, 2016) |
| "Giant molluscum contagiosum is a clinical variant in which large nodule greater than 0." | 2.50 | Cutaneous viral infections in organ transplant patients. ( Alaibac, M; Peserico, A; Piaserico, S; Sandini, E, 2014) |
| "Infection with varicella-zoster virus (VZV) contemporaneously with malignant disease or immunosuppression represents a particular challenge and requires individualized decisions and treatment." | 1.37 | Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis. ( Beer, M; Eyrich, M; Gattenlöhner, S; Girschick, HJ; Liese, J; Schick, J; Schlegel, PG; Weissbrich, B; Wiegering, V, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piaserico, S | 1 |
| Sandini, E | 1 |
| Peserico, A | 1 |
| Alaibac, M | 1 |
| De, SK | 1 |
| Hart, JC | 1 |
| Breuer, J | 1 |
| Mullane, KM | 1 |
| Nuss, C | 1 |
| Ridgeway, J | 1 |
| Prichard, MN | 1 |
| Hartline, CB | 1 |
| Theusch, J | 1 |
| Mommeja-Marin, H | 1 |
| Larson, RA | 1 |
| Voigt, S | 1 |
| Hofmann, J | 1 |
| Edelmann, A | 1 |
| Sauerbrei, A | 1 |
| Kühl, JS | 1 |
| Wiegering, V | 1 |
| Schick, J | 1 |
| Beer, M | 1 |
| Weissbrich, B | 1 |
| Gattenlöhner, S | 1 |
| Girschick, HJ | 1 |
| Liese, J | 1 |
| Schlegel, PG | 1 |
| Eyrich, M | 1 |
| Ramos, C | 1 |
| Lajusticia, J | 1 |
| Tan, HH | 1 |
| Goh, CL | 1 |
| Schliefer, K | 1 |
| Gümbel, HO | 1 |
| Rockstroh, JK | 1 |
| Spengler, U | 1 |
| Turner, RW | 1 |
| Grigsby, TH | 1 |
| Enright, JR | 1 |
| Chance, HL | 1 |
| Frazier, TC | 1 |
| Womack, CT | 1 |
| Lang, EK | 1 |
3 reviews available for cytosine and Herpes Zoster
| Article | Year |
|---|---|
Cutaneous viral infections in organ transplant patients.
Topics: Acitretin; Administration, Cutaneous; Aminoquinolines; Antiviral Agents; Cidofovir; Cytosine; Dermat | 2014 |
Herpes simplex virus and varicella zoster virus: recent advances in therapy.
Topics: Antiviral Agents; Clinical Trials as Topic; Cytosine; Drug Discovery; Drug Evaluation; Drug Resistan | 2015 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Ad | 2006 |
6 other studies available for cytosine and Herpes Zoster
| Article | Year |
|---|---|
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antineoplastic Agents; Antiviral Agents; Cytosine; Drug Re | 2016 |
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Chi | 2016 |
Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis.
Topics: Acyclovir; Antiviral Agents; Chickenpox; Child; Child, Preschool; Cidofovir; Cytosine; Female; Herpe | 2011 |
[Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Re | 2004 |
Management of progressive outer retinal necrosis with cidofovir in a human immunodeficiency virus-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Herpes Zoster; | 1999 |
Anuria secondary to mechanical obstruction caused by a Candida fungus ball.
Topics: Anuria; Candida albicans; Candidiasis; Contrast Media; Cytosine; Female; Fluorine; Herpes Zoster; Hu | 1973 |